Results 131 to 140 of about 209,474 (310)

Epidemiology of hospitalized heart failure in France based on national data over 10 years, 2012–2022

ESC Heart Failure, Volume 12, Issue 2, Page 1283-1294, April 2025.
Abstract Aims We aim to describe the incidence of HF hospitalization in France in the post‐pandemic era, the prevalence of HF cases and patients' characteristics, management and outcomes while focusing on sex, age and socio‐economic differences and to analyse time‐trends between 2012 and 2022.
Valérie Olié, Richard Isnard, Françoise Pousset, Clémence Grave, Jacques Blacher, Amélie Gabet   +5 more
wiley   +1 more source

Approximation of epidemic models by diffusion processes and their statistical inference

, 2013
Romain Guy, Catherine Larédo, Elisabeta Vergu   +2 more
openalex   +1 more source

Dapagliflozin alleviates high‐fat‐induced obesity cardiomyopathy by inhibiting ferroptosis

ESC Heart Failure, Volume 12, Issue 2, Page 1358-1373, April 2025.
Abstract Aim: Dapagliflozin (Dapa) is a novel hypoglycaemic agent with multiple cardiovascular protective effects, and it is widely used in treatment of heart failure patients, but whether it can improve obese phenotype of heart failure and its mechanism is still unclear.
Di Chen, Jiahao Shi, Yue Wu, Lizhu Miao, Zilin Wang, Yixuan Wang, Siwei Xu, Yu Lou   +7 more
wiley   +1 more source

West Nile Fever: Analysis of the Epidemiological Situation in the Russian Federation in 2023, Forecast for 2024

Проблемы особо опасных инфекций
An analysis of the epidemiological situation on West Nile fever (WNF) in the Russian Federation in 2023 has revealed an increase in the number of cases (210) relative to the year 2022 by 6.3 times, the long-term average value by 1.2 times. Manifestations
E. V. Putintseva, S. K. Udovichenko, D. N. Nikitin, N. V. Boroday, A. S. Antonov, A. V. Toporkov   +5 more
doaj   +1 more source

Cilostazol in patients with heart failure and preserved ejection fraction—The CLIP‐HFpEF trial

ESC Heart Failure, Volume 12, Issue 2, Page 1437-1446, April 2025.
• Cilostazol is an oral PDE‐3 inhibitor that may have advantageous effects in heart failure with preserved ejection fraction (HFpEF). • Cilostazol significantly improved short‐term heart failure‐related health status scores (KCCQ‐12) and NT‐proBNP levels when compared to placebo.
Norman Aiad, Jeanne du Fay de Lavallaz, Michael J. Zhang, Thanat Chaikijurajai, Bo Ye, Prabhjot S. Nijjar, Julie A. Lahiri, Cindy M. Martin, Tamas Alexy, Markus Meyer   +9 more
wiley   +1 more source

Current epidemiology of pertussis and problem issues of vaccine prophylaxis of this infection

Zdorovʹe Rebenka
Background. Whole-cell and acellular pertussis vaccines are used for the prevention of the disease. Following the COVID-19 pandemic, an increase in pertussis incidence has been observed in several countries, indicating a decline in vaccine-controlled ...
В.І. Задорожна, Н.П. Винник, Т.А. Сергеєва, А.П. Подаваленко   +3 more
doaj   +1 more source

Winning Legitimacy and Dodging Blame: How Government Communication Shapes Media Sentiments and Responsibility Attribution in Consensus Democracies

European Policy Analysis, EarlyView.
ABSTRACT How do governments' discursive credit‐claiming and blame‐deflection strategies shape perceived policy legitimacy in times of crisis? Despite the importance of legitimacy in conflictual times, systematic analyses of officeholders' credit‐claiming and blame‐deflection strategies and their effect on perceived legitimacy are still rare.
Céline Honegger
wiley   +1 more source

A theoretical framework for agent-based modelling of infectious disease dynamics under misinformation and vaccine hesitancy

Радіоелектронні і комп'ютерні системи
The relevance of this study stems from the growing importance of modelling not only the biological transmission of infectious diseases but also the behavioural and informational factors that shape real-world epidemic dynamics. The subject of the research
Dmytro Chumachenko
doaj   +1 more source

What happened after the epidemic? Equine influenza surveillance sheds light on sources and seasonal risk in the United Kingdom

Equine Veterinary Journal, EarlyView.
Abstract Background The epidemiology of equine influenza (EI) in the United Kingdom has not been systematically described since the 2019 epidemic. Objectives To summarise UK EI surveillance (2020–2024), quantify outbreak seasonality and assess movement‐related sources. Study Design Retrospective observational analysis of national surveillance and horse
Fleur Whitlock, John Grewar, Richard Newton   +2 more
wiley   +1 more source

Understanding the Anticontagion Process and Reopening of China during COVID‐19 via Coevolution Network of Epidemic and Awareness [PDF]

, 2021
Lingbo Li, Ying Fan, An Zeng, Zengru Di
openalex   +1 more source